At Pathfinder Lab, we’re not just following the path—we’re forging it. True to our name, we are dedicated to finding new ways in pathology, leveraging the power of digital pathology and artificial intelligence (AI) to revolutionize cancer diagnostics.

Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images, with a particular focus on cancer detection. Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images.

Our strength lies in our partnerships. By collaborating with leading university hospitals, such as the University Hospital Zurich and Women’s Hospital, we’ve built a robust network that combines academic expertise with clinical insights.

One of our core goals is to democratize access to advanced diagnostic tools. We’re proud to announce that our software has been adopted by over 50 mid-sized hospitals across North America and Europe, enabling them to provide high-quality pathology services without the need for in-house expertise. Additionally, we’ve partnered with government health agencies in Canada and the UK to integrate our AI-driven diagnostics into national healthcare systems, improving diagnostic accuracy for unders

We’re excited to continue sharing our work with the global pathology community. Next month, Pathfinder Lab will be presenting at the International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2025, where we’ll introduce a new computational framework for kidney transplant outcome prediction.A

As we continue to innovate, our slogan—“Pioneering the Field of Digital Pathology with Challenge and Expertise”—remains at the heart of everything we do.